Intranasal Corticosteroids Global Market Report 2025
상품코드:1810926
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
경비 코르티코스테로이드 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 7.6%로 90억 7,000만 달러로 성장합니다. 예측 기간의 성장은 저침습적 치료에 대한 관심 증가, 기후 변화로 인한 알레르기 질환 발병률 증가, 자가 투여 치료에 대한 선호도 증가, 비강 병용 요법 채택 확대, 알레르기 관리를 위한 디지털 건강 지원 강화 등이 견인할 것으로 보입니다. 이 기간의 주요 동향으로는 용량 모니터링을 위한 스마트 기기 통합, 무방부제 비강 점안제 혁신, 소아 친화적 제제 개발, 스테로이드가 없는 보조 요법의 발전, 치료 추적을 위한 e-헬스 플랫폼의 도입 등이 있습니다.
알레르기성 비염의 유병률 증가는 향후 수년간 비강내 코르티코스테로이드 시장의 성장을 가속할 것으로 예측됩니다. 알레르기성 비염은 비강에 염증을 일으키는 알레르기 반응으로 보통 꽃가루, 진드기, 곰팡이, 반려동물의 비듬과 같은 공기 중 알레르겐에 의해 발생합니다. 이 질환은 주로 환경오염 증가로 인해 비강내 알레르기 반응을 유발하는 알레르겐이나 자극 물질에 노출될 기회가 많아지면서 흔해지고 있습니다. 비강 코르티코스테로이드는 비강내 염증을 억제하고 재채기, 코막힘, 콧물 등의 증상을 완화합니다. 예를 들어 2023년 10월 미국 국립의학도서관은 알레르기성 비염은 전 세계에서 4억 명 이상이 앓고 있으며, 유병률은 성인의 경우 10%에서 30%, 소아의 경우 40% 이상의다고 보고했습니다. 따라서 알레르기성 비염 환자 증가는 비강내 코르티코스테로이드 시장을 촉진하고 있습니다.
비강 코르티코스테로이드 시장의 주요 업체들은 표적 약물전달을 개선하고 환자의 순응도를 높이기 위해 비강 점적제와 같은 혁신적인 제형을 개발하고 있습니다. 비강 스프레이는 알레르기, 코막힘, 염증을 치료하기 위해 스프레이 노즐을 통해 액상 약물을 코에 직접 투여합니다. 코 점막의 빠른 약물 흡수를 촉진하여 전신 부작용을 최소화하면서 빠른 완화를 제공합니다. 예를 들어 2024년 3월 미국 제약회사 옵티노즈(OptiNose Inc.)는 비용종이 없는 만성 비부비동염(CRS) 성인에 특화된 최초의 치료제인 XHANCE의 FDA 승인을 획득했습니다. 이 비강 분무기는 독자적인 호흡 전달 시스템을 통해 비강 깊숙이 약물을 침투시켜 성인 비용종 유무에 관계없이 CRS를 효과적으로 관리할 수 있습니다. 각 스프레이는 플루티카손 프로피오네이트 93mcg을 공급하며, 사용자가 마우스피스에 숨을 불어넣는 동시에 스프레이를 콧구멍으로 방출하여 정확한 전달과 증상 완화를 보장하는 방식으로 작동합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 경비 코르티코스테로이드 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 경비 코르티코스테로이드 시장 : 성장률 분석
세계의 경비 코르티코스테로이드 시장 실적 : 규모와 성장, 2019-2024
세계의 경비 코르티코스테로이드 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 경비 코르티코스테로이드 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 경비 코르티코스테로이드 시장 : 약제 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
처방약
OTC(Over-the-Counter)
세계의 경비 코르티코스테로이드 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
알레르기성 비염
코폴립
부비강염
기타 용도
세계의 경비 코르티코스테로이드 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 경비 코르티코스테로이드 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
홈케어
헬스케어 프로바이더
세계의 경비 코르티코스테로이드 시장 : 서브 세분화, 처방약(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
Fluticasone Propionate
Mometasone Furoate
Budesonide
Beclomethasone Dipropionate
Ciclesonide
세계의 경비 코르티코스테로이드 시장 : 서브 세분화, OTC(Over-the-Counter)(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
Triamcinolone Acetonide
Fluticasone Furoate
Budesonide OTC(Over-the-Counter) Drugs
제7장 지역별·국가별 분석
세계의 경비 코르티코스테로이드 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 경비 코르티코스테로이드 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
경비 코르티코스테로이드 시장 : 경쟁 구도
경비 코르티코스테로이드 시장 : 기업 개요
GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
Sandoz Group AG Overview, Products and Services, Strategy and Financial Analysis
Haleon plc Overview, Products and Services, Strategy and Financial Analysis
Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Organon Pharma(UK) Limited
Sun Pharmaceutical Industries Ltd.
Apotex Inc.
Perrigo Company plc
Aurobindo Pharma Limited
Cipla Ltd.
Hikma Pharmaceuticals plc
Zydus Lifesciences Ltd.
Glenmark Pharmaceuticals Limited
OptiNose US Inc.
Taro Pharmaceutical Industries Ltd.
Maya Biotech Private Limited
AdvaCare Pharma USA
Lupin Ltd.
Xenone Healthcare Private Limited.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
경비 코르티코스테로이드 시장 2029 : 새로운 기회를 제공하는 국가
경비 코르티코스테로이드 시장 2029 : 새로운 기회를 제공하는 부문
경비 코르티코스테로이드 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Intranasal corticosteroids are anti-inflammatory drugs administered through the nose to treat conditions like allergic rhinitis and nasal polyps. They work by reducing swelling, congestion, and mucus production in the nasal passages, thereby improving breathing and alleviating allergy symptoms.
The main categories of intranasal corticosteroids include prescription and over-the-counter drugs. Prescription intranasal corticosteroids are doctor-approved medications used to manage moderate to severe allergic rhinitis or chronic nasal inflammation, often favored for long-term or specialized treatment under medical guidance. These drugs are applied to treat allergic rhinitis, nasal polyps, sinusitis, and related conditions. They are distributed through various channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others, and are utilized by a range of end users including hospitals, clinics, homecare settings, and healthcare providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The intranasal corticosteroids market research report is one of a series of new reports from The Business Research Company that provides intranasal corticosteroids market statistics, including intranasal corticosteroids global market size, regional shares, competitors with intranasal corticosteroids market share, detailed intranasal corticosteroids market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal corticosteroids industry. The intranasal corticosteroids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intranasal corticosteroids market size has grown strongly in recent years. It will grow from $6.29 billion in 2024 to $6.78 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. Growth during the historic period can be attributed to the rising prevalence of allergic rhinitis, an increasing incidence of chronic sinusitis, greater awareness of non-oral treatment options, expanded use in pediatric allergic conditions, and improved availability of over-the-counter intranasal products.
The intranasal corticosteroids market size is expected to see strong growth in the next few years. It will grow to $9.07 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. Growth in the forecast period is expected to be driven by an increasing focus on minimally invasive therapies, a rising incidence of allergic diseases linked to climate change, growing preference for self-administered treatments, wider adoption of combination intranasal therapies, and enhanced digital health support for allergy management. Key trends during this period include the integration of smart devices for dose monitoring, innovations in preservative-free nasal sprays, development of pediatric-friendly formulations, advancement of steroid-free adjunct therapies, and the incorporation of e-health platforms for treatment tracking.
The growing prevalence of allergic rhinitis is expected to drive the expansion of the intranasal corticosteroids market in the coming years. Allergic rhinitis is an allergic reaction that causes inflammation in the nasal passages, usually triggered by airborne allergens like pollen, dust mites, mold, or pet dander. This condition is becoming more common primarily due to increasing environmental pollution, which exposes people to allergens and irritants that provoke allergic responses in the nasal passages. Intranasal corticosteroids work by reducing inflammation in the nasal passages, alleviating symptoms such as sneezing, congestion, and runny nose. For example, in October 2023, the National Library of Medicine reported that allergic rhinitis affects over 400 million individuals globally, with prevalence rates ranging from 10% to 30% in adults and exceeding 40% in children. Therefore, the rise in allergic rhinitis cases is boosting the intranasal corticosteroid market.
Key players in the intranasal corticosteroids market are developing innovative formulations like nasal sprays to improve targeted drug delivery and enhance patient adherence. Nasal sprays administer liquid medication directly into the nose via a spray nozzle to treat allergies, congestion, or inflammation. They facilitate rapid drug absorption through the nasal mucosa, providing quick relief while minimizing systemic side effects. For instance, in March 2024, OptiNose Inc., a US pharmaceutical company, gained FDA approval for XHANCE, the first treatment specifically indicated for adults with chronic rhinosinusitis (CRS) without nasal polyps. This nasal spray features a unique exhalation delivery system that allows the medication to penetrate deeply into the nasal cavity, effectively managing CRS with or without nasal polyps in adults. Each spray delivers 93 mcg of fluticasone propionate, and the device works by having the user blow into a mouthpiece while simultaneously releasing the spray into the nostril, ensuring precise delivery and improved symptom relief.
In April 2023, SK Capital Partners LP, a US-based investment firm, acquired Apotex for an undisclosed sum. This acquisition aims to strengthen Apotex's global standing in affordable pharmaceuticals by supporting growth, enhancing operational efficiency, and fostering product innovation. Apotex Inc. is a Canada-based manufacturer of intranasal corticosteroid sprays.
Major players in the intranasal corticosteroids market are GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Haleon plc, Intas Pharmaceuticals Limited, Organon Pharma (UK) Limited, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Ltd., Hikma Pharmaceuticals plc, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, OptiNose US Inc., Taro Pharmaceutical Industries Ltd., Maya Biotech Private Limited, AdvaCare Pharma USA, Lupin Ltd., Xenone Healthcare Private Limited.
North America was the largest region in the intranasal corticosteroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intranasal corticosteroids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the intranasal corticosteroids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The intranasal corticosteroids market consists of sales of fluticasone propionate nasal spray, mometasone furoate nasal spray, budesonide nasal spray, beclomethasone dipropionate nasal spray, and triamcinolone acetonide nasal spray. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intranasal Corticosteroids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on intranasal corticosteroids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for intranasal corticosteroids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intranasal corticosteroids market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Types: Prescribed Drugs; Over-The-Counter Drugs
2) By Application: Allergic Rhinitis; Nasal Polyps; Sinusitis; Other Applications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channel
4) By End User: Hospitals; Clinics; Homecare; Healthcare Providers
3. Intranasal Corticosteroids Market Trends And Strategies
4. Intranasal Corticosteroids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Intranasal Corticosteroids Growth Analysis And Strategic Analysis Framework
5.1. Global Intranasal Corticosteroids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Intranasal Corticosteroids Market Growth Rate Analysis
5.4. Global Intranasal Corticosteroids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Intranasal Corticosteroids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Intranasal Corticosteroids Total Addressable Market (TAM)
6. Intranasal Corticosteroids Market Segmentation
6.1. Global Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescribed Drugs
Over-The-Counter Drugs
6.2. Global Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergic Rhinitis
Nasal Polyps
Sinusitis
Other Applications
6.3. Global Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channel
6.4. Global Intranasal Corticosteroids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare
Healthcare Providers
6.5. Global Intranasal Corticosteroids Market, Sub-Segmentation Of Prescribed Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluticasone Propionate
Mometasone Furoate
Budesonide
Beclomethasone Dipropionate
Ciclesonide
6.6. Global Intranasal Corticosteroids Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Triamcinolone Acetonide
Fluticasone Furoate
Budesonide Over-The-Counter Drugs
7. Intranasal Corticosteroids Market Regional And Country Analysis
7.1. Global Intranasal Corticosteroids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Intranasal Corticosteroids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Intranasal Corticosteroids Market
9.1. China Intranasal Corticosteroids Market Overview
9.2. China Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Intranasal Corticosteroids Market
10.1. India Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Intranasal Corticosteroids Market
11.1. Japan Intranasal Corticosteroids Market Overview
11.2. Japan Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Intranasal Corticosteroids Market
12.1. Australia Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Intranasal Corticosteroids Market
13.1. Indonesia Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Intranasal Corticosteroids Market
14.1. South Korea Intranasal Corticosteroids Market Overview
14.2. South Korea Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Intranasal Corticosteroids Market
15.1. Western Europe Intranasal Corticosteroids Market Overview
15.2. Western Europe Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Intranasal Corticosteroids Market
16.1. UK Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Intranasal Corticosteroids Market
17.1. Germany Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Intranasal Corticosteroids Market
18.1. France Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Intranasal Corticosteroids Market
19.1. Italy Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Intranasal Corticosteroids Market
20.1. Spain Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Intranasal Corticosteroids Market
21.1. Eastern Europe Intranasal Corticosteroids Market Overview
21.2. Eastern Europe Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Intranasal Corticosteroids Market
22.1. Russia Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Intranasal Corticosteroids Market
23.1. North America Intranasal Corticosteroids Market Overview
23.2. North America Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Intranasal Corticosteroids Market
24.1. USA Intranasal Corticosteroids Market Overview
24.2. USA Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Intranasal Corticosteroids Market
26.1. South America Intranasal Corticosteroids Market Overview
26.2. South America Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Intranasal Corticosteroids Market
27.1. Brazil Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Intranasal Corticosteroids Market
28.1. Middle East Intranasal Corticosteroids Market Overview
28.2. Middle East Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Intranasal Corticosteroids Market
29.1. Africa Intranasal Corticosteroids Market Overview
29.2. Africa Intranasal Corticosteroids Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Intranasal Corticosteroids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Intranasal Corticosteroids Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Intranasal Corticosteroids Market Competitive Landscape And Company Profiles
